phosphoramidic acid has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coyne, CP; Narayanan, L | 1 |
| Dikmen, ZG; Gryaznov, SM; Jackson, SR; Paulson, V; Shay, JW; Watkins, L; Wright, WE; Zhu, CH | 1 |
2 other study(ies) available for phosphoramidic acid and Lung Neoplasms
| Article | Year |
|---|---|
Mebendazole in simultaneous combination with dexamethasone-(C
Topics: Adenocarcinoma of Lung; Amides; Antineoplastic Agents; Dexamethasone; ErbB Receptors; Humans; Lung Neoplasms; Mebendazole; Phosphoric Acids | 2019 |
Antiadhesive effects of GRN163L--an oligonucleotide N3'->P5' thio-phosphoramidate targeting telomerase.
Topics: Amides; Animals; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Line, Tumor; Humans; Lung Neoplasms; Mice; Mice, Nude; Oligonucleotides; Oligopeptides; Phosphoric Acids; RNA; Telomerase; Telomere; Xenograft Model Antitumor Assays | 2007 |